World Malaria Day 2026: A Rallying Cry
On World Malaria Day 2026, the World Health Organization joins partners to launch the campaign: “Driven to End Malaria: Now We Can. Now We Must.” a rallying cry to protect lives now and fund a malaria-free future. Since 2000, 2.3 billion cases and 14 million deaths have been averted, and 47 countries have been certified malaria-free. Yet for Africa, the battle is far from over.
The Scale of Africa’s Malaria Crisis
Malaria remains a major public health burden in Africa, which now accounts for over 270 million cases and around 595,000 deaths annually representing nearly all global cases and deaths.
The WHO has warned that a projected $45 billion funding gap between 2026 and 2030 could derail global efforts to eliminate malaria, even as Africa continues to record nearly 600,000 deaths annually. The economic burden is equally severe: beyond direct treatment costs, malaria leads to lost workdays, reduced household income and increased pressure on already stretched health systems.
The disease does not strike equally. Child mortality is increasingly driven by overlapping conditions such as malaria, malnutrition, and pneumonia, revealing a major weakness in health systems still largely structured around single diseases rather than integrated care.
Why Malaria Remains Unsolved in Primary Healthcare
Despite decades of intervention, several converging forces are pushing back against progress:
Drug Resistance
Artemisinin partial resistance is now confirmed in four African countries Eritrea, Rwanda, Uganda, and the United Republic of Tanzania and is spreading. This is a critical danger to the main treatments for malaria.
Insecticide Resistance
Resistance to pyrethroids the main chemical used on bed nets is widespread, confirmed in 48 out of 53 reporting countries.
Diagnostic Failure
Gene deletions that can make rapid diagnostic tests fail are spreading and are now reported in 46 endemic countries. Additionally, the invasive mosquito Anopheles stephensi, an urban-dwelling, insecticide-resistant species, is expanding its range in Africa, posing a new threat to cities.
A Fragmented Health System
Decades of reliance on vertical health programmes that focus on specific diseases and operate in parallel to national systems have not consistently built resilient, coordinated health systems. Much of Africa’s health research has been shaped by external funding priorities, leaving a gap between evidence generation and practical application with locally produced data often failing to influence policy or frontline healthcare delivery.
Cost Barriers at the Community Level
Many Africans, especially those in rural and peri-urban areas, still depend on folk medicine as a major source of healthcare because it is readily available, conventional medicine is expensive, and there is a lack of adequate healthcare facilities and limited access to allopathic medicine.
The Case for Complementary & Alternative Medicine (CAM)
Africa’s traditional healers have long held knowledge of plant-based remedies for malaria. Today, modern science is increasingly validating what communities have practiced for generations while also calling for greater rigor and integration.
The Precedent: Artemisinin Itself is a Plant Medicine
Traditional medicine has been a cornerstone of healthcare across various cultures, especially in Africa. Drawing on the success of plants like Artemisia annua in the development of modern anti-malarial drugs, researchers emphasize the need for comprehensive investment in traditional medicine research since previously successful antimalarial drugs such as quinine and artemisinin both originate from plants.
Key Medicinal Plants Showing Promise
Neem (Azadirachta indica)
Neem rapidly kills the schizonts and gametocytes of Plasmodium falciparum, and is a low-cost alternative to ACT. While it would cost approximately $20–$100 to treat acute malaria with current therapies, herbal remedies like neem range from $1 to $2. Many West African countries, including Ghana, already use neem where people commonly boil its leaves and drink it as tea.
Cryptolepis sanguinolenta (Ghanaian Quinine)
A study in Ghana’s Greater Accra Region identified 44 plant species from 28 families used in herbal antimalarial products. Cryptolepis sanguinolenta and Azadirachta indica were the most frequently cited, with Cryptolepis used in 17 different finished herbal products. These locally manufactured herbal antimalarials are important for the treatment of malaria in both urban and rural communities.
Maytenus senegalensis (Spike Horn)
Maytenus senegalensis, a herbal remedy traditionally used across Benin, Ivory Coast, Kenya, Sudan, Tanzania, Zambia, and Zimbabwe, has been confirmed as safe and effective for treating malaria in a clinical trial. Scientists noted the remedy could also help fight artemisinin-resistant malaria and that it did not pose any significant risk to the heart, suggesting it could be safer than some conventional medicines in resistant-malaria contexts.
Plants Used Across West Africa
In Nigeria, 62 indigenous medicinal plants have been identified for malaria treatment. The most commonly used include Mangifera indica (mango), Enantia chlorantha, Alstonia boonei, and Cymbopogon citratus (lemongrass). The antimalarial activities of many of these plants and their isolated phytocompounds have already been demonstrated scientifically.
In Uganda, Vernonia amygdalina (bitter leaf), Bidens pilosa, and Justicia betonica were the most highly cited plants used in malaria treatment. Traditional medicine practitioners emphasize the use of leaves and bark, which can regenerate and ensure sustainable use of plants and these healers also actively counsel patients on prevention measures such as sleeping under mosquito nets and clearing bushes near homesteads.
CAM’s Strengths in Primary Healthcare Settings
In Ghana, the popularity of alternative herbal malaria treatments is rapidly growing due to easy access, low cost, and perceived benefits. Some of these herbal medicines contain compounds in the same chemical classes as standard ACT partner drugs.
CAM offers several practical advantages in resource-limited African primary health care settings:
Accessibility: Available locally in rural and remote communities where clinics are scarce
Affordability: Costing a fraction of conventional ACT treatment
Cultural acceptance: Deeply embedded in community trust and generational practice
Resistance potential: Some plants target the parasite at multiple stages, potentially slowing resistance development
Challenges & the Path to Integration
Although the use of herbal remedies to treat malaria in sub-Saharan Africa is far from a new concept, robust research and clinical trials on this subject remain limited.
Scientific validation remains a key challenge, hindering the widespread acceptance of traditional medicine in modern healthcare systems. Advocates call for increased funding, scientific investigations into the efficacy of traditional remedies, and enhanced regulation of herbal medicine.
Primary healthcare systems remain central to malaria prevention and treatment, particularly in delivering early diagnosis and timely care at the community level. Health officials stress the need for a whole-of-society response involving sectors such as health, education, agriculture, environment, housing, and finance noting that malaria control depends on coordinated action beyond the health sector alone.
Conclusion: Two Systems, One Goal
The fight against malaria in Africa cannot be won by conventional medicine alone not while drug resistance is spreading, funding gaps persist, and millions of rural Africans cannot afford or access orthodox care. Complementary and Alternative Medicine, rooted in centuries of indigenous wisdom and increasingly validated by modern science, offers a credible, affordable, and community-driven complement to standard treatment.
With the tools and resources available today, no one should die from malaria. Achieving that vision means embracing all available tools including Africa’s own medicinal heritage through rigorous research, proper regulation, and genuine integration into primary health care systems.
On this World Malaria Day 2026, the message is clear: the path to ending malaria runs through the community, the clinic, and the forest together.
Mustapha Bature Sallama.
Medical/ Science Communicator,
Private Investigator, Criminal investigation and Intelligence Analysis.
International Conflict Management and Peace Building.USIP
mustysallama@gmail.com
+233-555-275-880
